Takeda's Alogliptin Suffers Major Setback, Delaying Drug Launch Until 2012 Or Later
This article was originally published in The Pink Sheet Daily
Executive Summary
Negative news increases pressure on Japanese pharma's oncology subsidiary Millennium Pharmaceuticals to perform.